Chemfab Alkalis Ltd
Incorproated in 2009, Chemfab
Alkalis Ltd manufactures basic
inorganic chemicals and PVCO
pipes[1]
- Market Cap ₹ 958 Cr.
- Current Price ₹ 667
- High / Low ₹ 1,230 / 645
- Stock P/E 347
- Book Value ₹ 265
- Dividend Yield 0.19 %
- ROCE 3.33 %
- ROE -0.96 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.52 times its book value
- The company has delivered a poor sales growth of 10.3% over past five years.
- Company has a low return on equity of 8.15% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|
205 | 181 | 272 | 331 | 327 | 334 | 349 | |
149 | 157 | 215 | 221 | 273 | 291 | 303 | |
Operating Profit | 55 | 24 | 57 | 111 | 55 | 44 | 47 |
OPM % | 27% | 13% | 21% | 33% | 17% | 13% | 13% |
-0 | 1 | 6 | 2 | 9 | -3 | -4 | |
Interest | 4 | 3 | 1 | 1 | 2 | 5 | 6 |
Depreciation | 25 | 20 | 22 | 23 | 22 | 36 | 35 |
Profit before tax | 27 | 2 | 39 | 89 | 39 | -0 | 2 |
Tax % | 5% | 500% | 26% | 28% | 33% | 2,210% | |
25 | -8 | 29 | 65 | 26 | -7 | -5 | |
EPS in Rs | 18.26 | -5.78 | 20.34 | 45.54 | 18.50 | -4.83 | -3.67 |
Dividend Payout % | 7% | 0% | 6% | 3% | 7% | -26% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 7% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -84% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 36% |
3 Years: | 45% |
1 Year: | -25% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 8% |
Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 262 | 253 | 284 | 347 | 373 | 366 |
43 | 32 | 9 | 2 | 20 | 84 | |
30 | 36 | 46 | 48 | 93 | 58 | |
Total Liabilities | 348 | 335 | 352 | 412 | 500 | 522 |
195 | 202 | 194 | 192 | 247 | 317 | |
CWIP | 35 | 3 | 8 | 31 | 74 | 36 |
Investments | 1 | 24 | 31 | 68 | 5 | 16 |
118 | 105 | 119 | 121 | 174 | 152 | |
Total Assets | 348 | 335 | 352 | 412 | 500 | 522 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
54 | 45 | 55 | 93 | 31 | 40 | |
-58 | -6 | -21 | -48 | -110 | -86 | |
3 | -16 | -25 | -9 | 16 | 59 | |
Net Cash Flow | -1 | 23 | 9 | 36 | -62 | 13 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 17 | 31 | 29 | 24 | 24 | 23 |
Inventory Days | 84 | 79 | 54 | 89 | 60 | 100 |
Days Payable | 165 | 154 | 92 | 145 | 101 | 118 |
Cash Conversion Cycle | -63 | -45 | -9 | -32 | -18 | 4 |
Working Capital Days | -2 | 15 | 5 | 7 | -24 | 46 |
ROCE % | 2% | 13% | 28% | 10% | 3% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Aug - Submission of Newspaper publication for the unaudited financial results for the quarter ended 30th June, 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1 Aug - Dear Sir/Madam, Please find the attached investor presentation for quarter ended on 30th June, 2025 for your reference
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1 Aug - Dear Sir/Madam, Please find the attached investor presentation for quarter ended on 30th June, 2025 for your reference
-
Reconstitution Of Committees
31 Jul - Allotment of 4,000 ESOP shares; ESOP scheme amended; director resigned; board committees reconstituted.
-
Announcement under Regulation 30 (LODR)-Change in Management
31 Jul - Board approved 4,000 ESOP shares allotment, ESOP scheme amendment, director resignation, and committee reconstitution.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
CAL is an ISO 14001 and OHSAS 18001 certified manufacturer of choloro alkali products. It uses Membrane Technology for Chloralkali production. Company also produces chlorine, hydrogen, sodium hypo chlorite, and hydrochloric acid as by-products from manufacture of caustic soda